| Today's Open | $41.36 |
|---|---|
| Previous Close | $41.57 |
| Daily Range | $41.34 - $41.73 |
| 52-Week Range | $31.28 - $41.73 |
| Market Cap | $11.1B |
| P/E Ratio | -346.42 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 544,508 |
| Average Daily Volume | 1,574,237 |
| Current FY EPS | $0.89 |
Sector
Healthcare
Industry
Drugs
Forest Laboratories, Inc. (FRX) Description
The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website: http://www.frx.com/
News & Commentary
Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Researc
Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Research Report on Teva, Forest, Pharmacyclics, Cubist, and Dr. Reddy'sUS Launch of Forest's Namenda XR - Analyst Blog
US Launch of Forest's Namenda XR - Analyst BlogForest Laboratories Becomes #156 Most Shorted S&P 500 Component, Replacing Air Products & Ch
Forest Laboratories Becomes #156 Most Shorted S&P 500 Component, Replacing Air Products & ChemicalsForest Announces Once-Daily NAMENDA XR Available in US
Forest Announces Once-Daily NAMENDA XR Available in USFRX's Top Competitors
(-0.02%)
(-0.03%)
(0.10%)
(0.59%)